Learn More
Medchemexpress LLC Lysophosphatidylcholine 18:2 | 22252-07-9 | 99.1% | 519.65 | 5 MG

Supplier: Medchemexpress LLC HYN94105MG
Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC) is a lysophospholipid identified as a potential biomarker for insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma levels of this compound are associated with impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment. It is classified as a human endogenous metabolite and is relevant to disease markers, infection, and endocrine diseases.
- Contributes to distinguishing between IR PCOS and control groups
- Associated with inflammation, insulin resistance, obesity, and type 2 diabetes
- A major class of glycerophospholipids in human plasma
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.